Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2008
Adherence to antiretrovirals among US women during and after pregnancyArlene D Bardeguez, Jane C Lindsey, Maureen Shannon, et al.
The Journal of Infectious Diseases|April 29, 2017
Inflammation and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1-Infected African Infants and Rotavirus Vaccine ResponsesPriyanka Uprety, Jane C Lindsey, Myron J Levin, et al.
Plos One|October 25, 2017
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African childrenLiusheng Huang, Vincent Carey, Jane C Lindsey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2019
Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for AgeDenise L Jacobson, Jane C Lindsey, Catherine Gordon, et al.
AIDS Patient Care and Stds|May 7, 2021
Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement InterventionK Rivet Amico, Jessica Crawford, Ini Ubong, et al.
Open Forum Infectious Diseases|November 29, 2024
Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected ChildrenMatthew S Kelly, Coleen K Cunningham, Elizabeth J McFarland, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Long-term observation of adolescents initiating HAART therapy: three-year follow-upPatricia M Flynn, Bret J Rudy, Jane C Lindsey, et al.
The Journal of Infectious Diseases|June 25, 2004
Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapyPatricia M Flynn, Bret J Rudy, Steven D Douglas, et al.
AIDS (London, England)|April 15, 2015
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of ageAndrea L Ciaranello, Kathleen Doherty, Martina Penazzato, et al.
AIDS (London, England)|September 24, 2016
Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in AfricaMyron J Levin, Jane C Lindsey, Susan S Kaplan, et al.
Pageof 5